Nicole Lambert, See Remarks at MYRIAD GENETICS INC (MYGN), sold 945 shares at $34.50 ($33K) on 2021-08-27, disclosed to the SEC on 2021-08-30.
Scheduled sale ($33k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MYGN | SELL | 2021-10-04 | $45K | — | Filing → |
| MYGN | SELL | 2021-09-27 | $669K | — | Filing → |
| MYGN | SELL | 2021-04-20 | $339K | — | Filing → |